The US will start sharing its total pipeline of vaccines from AstraZeneca as soon as the vaccine clear federal security evaluations, the White House stated, with as many as 60 million doses anticipated to be out there for export within the coming months.
The transfer drastically expands on the Biden administration’s motion final month to share about 4 million doses of the vaccine with Mexico and Canada. The AstraZeneca vaccine is broadly in use around the globe however not but licensed by the US Food and Drug Administration.
The transfer comes because the White House is more and more assured concerning the provide of the three vaccines being administered within the US, significantly following the restart of the single-dose Johnson & Johnson shot over the weekend.
Given the sturdy portfolio of vaccines that the US already has and which have been licensed by the FDA, and provided that the AstraZeneca vaccine shouldn’t be licensed to be used within the US, we don’t want to use the AstraZeneca vaccine right here through the subsequent a number of months,” said White House COVID-19 coordinator Jeff Zients. “Therefore the U.S. is looking at options to share the AstraZeneca doses with other countries as they become available.
Read all of the Latest News and Breaking News right here
